MAIA Biotechnology, Inc.

2:45 PM - 3:00 PM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
MAIA Biotechnology, Inc. is a cutting-edge, early stage biotech company, dedicated to developing targeted cancer therapies with novel mechanisms of action that are intended to meaningfully improve and extend the lives of patients with cancer. A privately-held company based in Chicago and Houston, MAIA is led by a passionate, principled and dynamic management team with significant drug development experience, committed to advancing promising agents into trials in humans in the next 2-3 years.
Company Type:
Company Website:
Company HQ State:
Illinois
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
DGD-1202
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4